Characterization and prognostic value of LXR splice variants in triple-negative breast cancer
Open Access
- 2 October 2021
- Vol. 24 (10) , 103212
Abstract
No abstract availableKeywords
Funding Information
- University of Leeds
This publication has 44 references indexed in Scilit:
- Efficient cellular fractionation improves RNA sequencing analysis of mature and nascent transcripts from human tissuesBMC Biotechnology, 2013
- The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral ResponseImmunity, 2013
- Primer3—new capabilities and interfacesNucleic Acids Research, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Triple-Negative Breast Cancer: An Unmet Medical NeedThe Oncologist, 2011
- REAP: A two minute cell fractionation methodBMC Research Notes, 2010
- A liver X receptor (LXR)-β alternative splicing variant (LXRBSV) acts as an RNA co-activator of LXR-βBiochemical and Biophysical Research Communications, 2009
- Nuclear localization of liver X receptor α and β is differentially regulatedJournal of Cellular Biochemistry, 2006
- NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteinsNucleic Acids Research, 2004